3 ms·
It was easy even then. PCR and Sanger sequencing have been in wide use for a long time. Yes, Myriad did do a lot of streamlining and optimizing, but everything
by thronemonkey 14y ago
It was easy even then. PCR and Sanger sequencing have been in wide use for a long time. Yes, Myriad did do a lot of streamlining and optimizing, but everything they did was with preexisting technologies. There's nothing novel or innovative at all—they developed a very efficient analysis pipeline, but that's not something anyone should ever be awarded a patent for.
- anigbrowl 14y agoIn that case, why haven't their legal antagonists built their case around a straightforward prior art argument, instead of amking normative arguments about the patentability of human DNA?
- thronemonkey 14y agoNot sure, might have something to do with the ACLU/AMP wanting to set a wide reaching precedent that patents of endogenous DNA sequences are not ok? They won't just want to win the single case, they want to change the wider legal landscape concerning patents and biological science.